A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 with a Long Term Double-Blind Extension in Subjects with Mild to Moderate Alzheimer’s Disease.
A comparison of the efficacy of Behavioral Activation (BA) and Supportive Therapy (ST) to prevent cognitive decline in older African Americans with Mild Cognitive Impairment (MCI)
Improving Medication Adherence in Older African Americans with Diabetes
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
